Manila Times Business
Published Study Shows Clinically Significant Energy, Performance, and Metabolic Benefits of FutureCeuticals' Caffinity™
MOMENCE, Ill., June 10, 2026 /PRNewswire/ -- FutureCeuticals, Inc. is pleased to announce the peer-reviewed publication of clinical research demonstrating unique energy, performance, and metabolic benefits of Caffinity™, a proprietary ingredient derived from the Arabica coffee cherry (bean and fruit). This study, conducted by recognized experts in energy metabolism at the University of Exeter (UK), establishes Caffinity as the only clinically validated energy ingredient to deliver a natural comp
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available
Just now
Adaptive ML and AT&T Expand AI Collaboration to Scale Specialized Models Across Enterprise Workflows
Just now
LEIFRAS Co., Ltd. Announces Entry into Kawasaki City Through New School Club Support Contract
Just now
TOYO Co., Ltd. Secures Two Major Supply Agreements Totaling $185.6 Million in Cumulative Purchase Orders for the U.S. Market
Just now